Amedeo Smart

Free Medical Literature Service


 

Amedeo

Influenza

  Free Subscription

11.03.2024

3 Antimicrob Agents Chemother
4 Antiviral Res
1 BMC Pediatr
3 BMJ
2 Epidemiol Infect
2 Eur J Epidemiol
1 J Immunol
10 J Infect Dis
2 JAMA
2 MMWR Morb Mortal Wkly Rep
9 Pediatrics
1 PLoS Med
18 PLoS One
1 Proc Natl Acad Sci U S A
3 Virus Res



    Antimicrob Agents Chemother

  1. YANG H, Yu X, Hou W, Liu X, et al
    Effectiveness and safety of nirmatrelvir-ritonavir in kidney transplant recipients with severe kidney dysfunction infected with COVID-19.
    Antimicrob Agents Chemother. 2024 Jan 30:e0138423. doi: 10.1128/aac.01384.
    >> Share

  2. ZHANG R, Zhou J, Yan H, Liu X, et al
    Manidipine is not a potential inhibitor against SARS-CoV-2 main protease.
    Antimicrob Agents Chemother. 2024;68:e0129723.
    >> Share

  3. MIAH M, Davis AM, Hannoun C, Said JS, et al
    Identification of epidermal growth factor receptor-tyrosine kinase inhibitor targeting the VP1 pocket of human rhinovirus.
    Antimicrob Agents Chemother. 2024;68:e0106423.
    >> Share


    Antiviral Res

  4. GOTO T, Kawai N, Bando T, Takasaki Y, et al
    Virological and clinical outcomes in outpatients treated with baloxavir or neuraminidase inhibitors for A(H3N2) influenza: A multicenter study of the 2022-2023 season.
    Antiviral Res. 2024;224:105853.
    >> Share

  5. SINHA D, Yaugel-Novoa M, Waeckel L, Paul S, et al
    Unmasking the potential of secretory IgA and its pivotal role in protection from respiratory viruses.
    Antiviral Res. 2024 Feb 6:105823. doi: 10.1016/j.antiviral.2024.105823.
    >> Share

  6. WINIGER RR, Perez L
    Therapeutic antibodies and alternative formats against SARS-CoV-2.
    Antiviral Res. 2024 Jan 31:105820. doi: 10.1016/j.antiviral.2024.105820.
    >> Share

  7. BOGACHEVA MS, Kuivanen S, Potdar S, Hassinen A, et al
    Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome.
    Antiviral Res. 2024 Jan 23:105813. doi: 10.1016/j.antiviral.2024.105813.
    >> Share


    BMC Pediatr

  8. CUI J, Jia W, Li P, Zhang X, et al
    Influenza a H1N1 infection complicated with encephalopathy and acute pancreatitis: a case report.
    BMC Pediatr. 2024;24:156.
    >> Share


    BMJ

  9. WATTERSON A
    What we did not learn at the covid inquiry in Scotland: a gap analysis.
    BMJ. 2024;384:q491.
    >> Share

  10. AGIUS RM
    UK workers during the pandemic: inadequate protection and, consequently, increased risk.
    BMJ. 2024;384:q508.
    >> Share

  11. WISE J
    Covid-19 taskforce called for a new national vaccine agency to prepare for future pandemics.
    BMJ. 2024;384:q534.
    >> Share


    Epidemiol Infect

  12. BIRD O, Galiza EP, Baxter DN, Boffito M, et al
    The predictive role of symptoms in COVID-19 diagnostic models: A longitudinal insight.
    Epidemiol Infect. 2024;152:e37.
    >> Share

  13. WAITE LL, Nahhas A, Irvahn J, Garden G, et al
    COVID-19 passenger screening to reduce travel risk and translocation of disease.
    Epidemiol Infect. 2024;152:e36.
    >> Share


    Eur J Epidemiol

  14. NORSTROM T, Ramstedt M
    The impact of the COVID-19 pandemic on mortality in Sweden-Did it differ across socioeconomic groups?
    Eur J Epidemiol. 2024;39:137-145.
    >> Share

  15. YANG L, Chen W, Chen D, He J, et al
    Cohort profile: the China surgery and anesthesia cohort (CSAC).
    Eur J Epidemiol. 2024;39:207-218.
    >> Share


    J Immunol

  16. READ KA, Amici SA, Farsi S, Cutcliffe M, et al
    PRMT5 Promotes T follicular helper Cell Differentiation and Germinal Center Responses during Influenza Virus Infection.
    J Immunol. 2024 Mar 4:ji2300270. doi: 10.4049/jimmunol.2300270.
    >> Share


    J Infect Dis

  17. EGESKOV-CAVLING AM, Johannesen CK, Lindegaard B, Fischer TK, et al
    Underreporting and Misclassification of Respiratory Syncytial Virus-Coded Hospitalization Among Adults in Denmark Between 2015-2016 and 2017-2018.
    J Infect Dis. 2024;229.
    >> Share

  18. SHEIKH Z, Potter E, Li Y, Cohen RA, et al
    Validity of Clinical Severity Scores for Respiratory Syncytial Virus: A Systematic Review.
    J Infect Dis. 2024;229.
    >> Share

  19. OSEI-YEBOAH R, Zhu F, Wang X, Nair H, et al
    Respiratory Syncytial Virus-Associated Hospital Admissions by Deprivation Levels Among Children and Adults in Scotland.
    J Infect Dis. 2024;229.
    >> Share

  20. KENMOE S, Chu HY, Dawood FS, Milucky J, et al
    Burden of Respiratory Syncytial Virus-Associated Acute Respiratory Infections During Pregnancy.
    J Infect Dis. 2024;229.
    >> Share

  21. VAN ROEKEL C, Poukka E, Turunen T, Nohynek H, et al
    Effectiveness of Immunization Products Against Medically Attended Respiratory Syncytial Virus Infection: Generic Protocol for a Test-Negative Case-Control Study.
    J Infect Dis. 2024;229.
    >> Share

  22. CHAPPIN K, Besteman SB, Hennus MP, Wildenbeest JG, et al
    Airway and Blood Monocyte Transcriptomic Profiling Reveals an Antiviral Phenotype in Infants With Severe Respiratory Syncytial Virus Infection.
    J Infect Dis. 2024;229.
    >> Share

  23. OSEI-YEBOAH R, Johannesen CK, Egeskov-Cavling AM, Chen J, et al
    Respiratory Syncytial Virus-Associated Hospitalization in Adults With Comorbidities in 2 European Countries: A Modeling Study.
    J Infect Dis. 2024;229.
    >> Share

  24. JOHNSON M, Chelysheva I, Oner D, McGinley J, et al
    A Genome-Wide Association Study of Respiratory Syncytial Virus Infection Severity in Infants.
    J Infect Dis. 2024;229.
    >> Share

  25. HAK SF, Venekamp RP, Billard MN, van Houten MA, et al
    Substantial Burden of Nonmedically Attended RSV Infection in Healthy-Term Infants: An International Prospective Birth Cohort Study.
    J Infect Dis. 2024;229.
    >> Share

  26. LIM WW, Shuo F, Wong SS, Sullivan SG, et al
    Hemagglutination inhibition antibody titers mediate influenza vaccine efficacy against symptomatic influenza A(H1N1), A(H3N2), and B/Victoria infections.
    J Infect Dis. 2024 Mar 7:jiae122. doi: 10.1093.
    >> Share


    JAMA

  27. HARRIS E
    Millions of US Children Experience Range of Long COVID Effects.
    JAMA. 2024;331:726.
    >> Share

  28. RUBIN R
    When It Comes to SARS-CoV-2 Clearance, People Who are Immunocompromised Are Not All Alike.
    JAMA. 2024 Feb 14. doi: 10.1001/jama.2024.1014.
    >> Share


    MMWR Morb Mortal Wkly Rep

  29. DECUIR J, Payne AB, Self WH, Rowley EAK, et al
    Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged >/=18 Years - VISION and IVY Networks,
    MMWR Morb Mortal Wkly Rep. 2024;73:180-188.
    >> Share

  30. ESSER MB, Sherk A, Liu Y, Naimi TS, et al
    Deaths from Excessive Alcohol Use - United States, 2016-2021.
    MMWR Morb Mortal Wkly Rep. 2024;73:154-161.
    >> Share


    Pediatrics

  31. YONTS AB, Gaviria-Agudelo C, Kimberlin DW, O'Leary ST, et al
    Fall 2023 ACIP Update on Meningococcal, RSV, COVID-19, and Other Pediatric Vaccines.
    Pediatrics. 2023 Dec 14. doi: 10.1542/peds.2023-064990.
    >> Share

  32. CURNS AT, Rha B, Lively JY, Sahni LC, et al
    Respiratory Syncytial Virus-Associated Hospitalizations Among Children <5 Years Old: 2016 to 2020.
    Pediatrics. 2024;153:e2023062574.
    >> Share

  33. VANDERMORRIS A, Toulany A, McKinnon B, Tam MW, et al
    Sexual and Reproductive Health Outcomes Among Adolescent Females During the COVID-19 Pandemic.
    Pediatrics. 2024;153:e2023063889.
    >> Share

  34. GRUBB LK
    Sexual and Reproductive Health During the Pandemic: Vulnerable Populations Are Hit the Hardest.
    Pediatrics. 2024;153:e2023064523.
    >> Share

  35. RAO S, Gross RS, Mohandas S, Stein CR, et al
    Postacute Sequelae of SARS-CoV-2 in Children.
    Pediatrics. 2024;153:e2023062570.
    >> Share

  36. CARDEMIL CV, Cao Y, Posavad CM, Badell ML, et al
    Maternal COVID-19 Vaccination and Prevention of Symptomatic Infection in Infants.
    Pediatrics. 2024 Feb 9:e2023064252. doi: 10.1542/peds.2023-064252.
    >> Share

  37. AHMED A, Munoz FM, Muller WJ, Agwu A, et al
    Remdesivir for COVID-19 in Hospitalized Children: A Phase 2/3 Study.
    Pediatrics. 2024;153:e2023063775.
    >> Share

  38. FRINTNER MP, Leslie LK, Gottschlich EA, Starmer AJ, et al
    Pediatricians' Career Satisfaction and Wellbeing by Sex Before and During the COVID-19 Pandemic.
    Pediatrics. 2024;153:e2023063345.
    >> Share

  39. CHUA KP, Volerman A, Zhang J, Hua J, et al
    Antidepressant Dispensing to US Adolescents and Young Adults: 2016-2022.
    Pediatrics. 2024;153:e2023064245.
    >> Share


    PLoS Med

  40. MKOMA GF, Agyemang C, Benfield T, Rostila M, et al
    Risk of long COVID and associated symptoms after acute SARS-COV-2 infection in ethnic minorities: A nationwide register-linked cohort study in Denmark.
    PLoS Med. 2024;21:e1004280.
    >> Share


    PLoS One

  41. MANACAS LRA, Amorim RLO, Aguila A, Novo PC, et al
    Evaluation of hematological changes and immune response biomarkers as a prognostic factor in critical patients with COVID-19.
    PLoS One. 2024;19:e0297490.
    >> Share

  42. MADRAZO L, Choo-Foo J, Domecq MC, LaDonna KA, et al
    Illness presenteeism among physicians and trainees: Study protocol of a scoping review.
    PLoS One. 2024;19:e0297447.
    >> Share

  43. CONOLLY AR, Maben J, Abrams R, Harris R, et al
    'There was a pivotal moment'. The dynamics, transitions, adaptations and trajectories of nursing at the front-line in the UK during the COVID-19 pandemic.
    PLoS One. 2024;19:e0295394.
    >> Share

  44. HEDDEN L, Spencer S, Mathews M, Gard Marshall E, et al
    "Technology has allowed us to do a lot more but it's not necessarily the panacea for everybody": Family physician perspectives on virtual care during the COVID-19 pandemic and beyond.
    PLoS One. 2024;19:e0296768.
    >> Share

  45. SEALE H, Harris-Roxas B, Heywood AE, Abdi I, et al
    "It's no use saying it in English": A qualitative study exploring community leaders' perceptions of the challenges and opportunities with translating and interpreting COVID-19 related public health messaging to reach ethnic minorities in Australia.
    PLoS One. 2024;19:e0284000.
    >> Share

  46. BRESSER M, Erhardt RM, Shanaube K, Simwinga M, et al
    Evaluation of COVID-19 antigen rapid diagnostic tests for self-testing in Lesotho and Zambia.
    PLoS One. 2024;19:e0280105.
    >> Share

  47. PRADO ADS, Baldofski S, Kohls E, Rummel-Kluge C, et al
    International and domestic university students' mental health over the course of the COVID-19 pandemic in Germany: Comparison between 2020, 2021, and 2022.
    PLoS One. 2024;19:e0299812.
    >> Share

  48. HOOKHAM L, Cantrell L, Cose S, Freyne B, et al
    Seroepidemiology of SARS-CoV-2 in a cohort of pregnant women and their infants in Uganda and Malawi.
    PLoS One. 2024;19:e0290913.
    >> Share

  49. CHARQUERO-BALLESTER M, Walter JG, Rybner AS, Nissen IA, et al
    Emotions on Twitter as crisis imprint in high-trust societies: Do ambient affiliations affect emotional expression during the pandemic?
    PLoS One. 2024;19:e0296801.
    >> Share

  50. BUMYUT A, Thanapop S, Dwipayanti NMU
    Safety and health measures compliance during the COVID-19 pandemic for community-based tourism in Nakhon Si Thammarat, Thailand: A cross-sectional descriptive study.
    PLoS One. 2024;19:e0300030.
    >> Share

  51. LWIN MO, Sheldenkar A, Tng PL
    You must be myths-taken: Examining belief in falsehoods during the COVID-19 health crisis.
    PLoS One. 2024;19:e0294471.
    >> Share

  52. CRUICKSHANK M, Brazzelli M, Manson P, Torrance N, et al
    What is the impact of long-term COVID-19 on workers in healthcare settings? A rapid systematic review of current evidence.
    PLoS One. 2024;19:e0299743.
    >> Share

  53. DOMNICH A, Calabro GE
    Epidemiology and burden of respiratory syncytial virus in Italian adults: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0297608.
    >> Share

  54. KECHAGIAS KS, Laleye JD, Drmota J, Geropoulos G, et al
    Minimal change disease following COVID-19 vaccination: A systematic review.
    PLoS One. 2024;19:e0297568.
    >> Share

  55. GROSSMANN K, Risch M, Markovic A, Aeschbacher S, et al
    Sex-specific differences in physiological parameters related to SARS-CoV-2 infections among a national cohort (COVI-GAPP study).
    PLoS One. 2024;19:e0292203.
    >> Share

  56. SOW MS, Togo J, Simons LM, Diallo ST, et al
    Genomic characterization of SARS-CoV-2 in Guinea, West Africa.
    PLoS One. 2024;19:e0299082.
    >> Share

  57. HU X, Zhu B, Zhang B, Zeng L, et al
    Extreme risk spillovers between US and Chinese agricultural futures markets in crises: A dependence-switching copula-CoVaR model.
    PLoS One. 2024;19:e0299237.
    >> Share

  58. OCANA GUTIERREZ VR, Gonzalez Ramirez RA, Ocana Aguilar VA, Ocana Aguilar NG, et al
    The weekly P25 of the age of the influenza-like illness shows a higher correlation with COVID-19 mortality than rapid tests and could predict the evolution of COVID-19 pandemics in sentinel surveillance, Piura, Peru, 2021.
    PLoS One. 2024;19:e0295309.
    >> Share


    Proc Natl Acad Sci U S A

  59. KRETSCH RC, Xu L, Zheludev IN, Zhou X, et al
    Tertiary folds of the SL5 RNA from the 5' proximal region of SARS-CoV-2 and related coronaviruses.
    Proc Natl Acad Sci U S A. 2024;121:e2320493121.
    >> Share


    Virus Res

  60. ZHANG S, Wang P, Shi L, Wang C, et al
    Exploring COVID-19 causal genes through disease-specific Cis-eQTLs.
    Virus Res. 2024;342:199341.
    >> Share

  61. MONTENEGRO AFL, Clementino MAF, Yaochite JNU
    Type I interferon pathway genetic variants in severe COVID-19.
    Virus Res. 2024;342:199339.
    >> Share

  62. LIM T, Rajoriya S, Kim B, Natasha A, et al
    In vitro broad-spectrum antiviral activity of MIT-001, a mitochondria-targeted reactive oxygen species scavenger, against severe acute respiratory syndrome coronavirus 2 and multiple zoonotic viruses.
    Virus Res. 2024;342:199325.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016